An open, randomised, multicentre, phase I/II study to evaluate the safety and therapeutic efficacy of an investigational vaccination regimen versus Lamivudine, in adult patients with HBeAg negative, anti-HBe antibody positive chronic…, Trial ID M00026%2F016 | GSK